Navigation Links
Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
Date:5/15/2008

ROCKVILLE, Md., May 15 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it has completed enrollment in the Phase I/IIa study of its pandemic influenza vaccine including a total of approximately 230 subjects. Favorable interim results from the first phase of the study, which included dose-escalation in 70 healthy adult volunteers, were reported in December 2007. The interim findings suggested that the vaccine is well tolerated and immunogenic at the 15 microgram and 45 microgram dose levels. Based upon its review of these results, the Data and Safety Monitoring Board (DSMB) recommended that the study continue.

Enrollment has now been completed in the second phase of the trial, which includes approximately 160 healthy adult volunteers. The safety and immunogenicity of three vaccine doses (15 micrograms, 45 micrograms and 90 micrograms) as compared with placebo will be evaluated. Top-line results for this trial are expected in the third quarter.

"This is an important study because the safety data collected in this trial will also be used to support the safety database for our seasonal influenza vaccine program which is expected to begin with a Phase IIa study in the third quarter of this year. Completion of enrollment in the second portion of this Phase I/IIa pandemic influenza vaccine trial keeps us on target to announce top line results from this study in the third quarter," said Rahul Singhvi, President and Chief Executive Officer.

ABOUT NOVAVAX

Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent recombinant vaccines utilizing a new, efficient manufacturing solution. Additional information about Novavax is available at http://www.novavax.com and in the Company's
'/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
2. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
3. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
4. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
5. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
6. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
7. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
8. VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial
9. PacificGMP Completes GMP Product Fill for Trius Therapeutics
10. Cardinal Health Completes Enturia Acquisition
11. DaVita Clinical Research Completes Record Number of Renal Trials in 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Ala. , July 28, 2014 ... J. Tipton , Ph.D., President and CEO of ... the Controlled Release Society (CRS) for the 2014-2015 ... annual meeting on July 12 in ... 40 countries.  The Controlled Release ...
(Date:7/28/2014)...  Houston dentist , Dr. Behzad ... with Invisalign. With access to this increasingly popular ... straightened without feeling self-conscious in the process. Invisalign ... types of braces, but patients who choose Invisalign ... better support for their oral health and comfort ...
(Date:7/28/2014)... 2014 Concord Medical Services Holdings Limited ("Concord ... a leading specialty hospital management solution provider and operator ... centers in China , today announced ... declared a special cash dividend of US$0.30 per ordinary ... the Company,s outstanding ordinary shares. The total expense for ...
Breaking Medicine Technology:Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 3Houston Cosmetic Dentist, Dr. Behzad Nazari, Now Offers Orthodontic Treatment with Invisalign 2Concord Medical Declares Special Dividend 2
... trial conducted at Evergreen Healthcare shows that a new form ... improves the quality of life for patients and reduces the ... walking. Evergreen was the only site in the ... Dr. C. Warren Olanow, a Fellow of the American Academy ...
... April 20, 2012  CVS Caremark Corporation (NYSE: ... Wednesday, May 2, 2012, at 8:30 a.m. (EDT) with ... financial results. (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO ) ... will be broadcast simultaneously through the Investor Relations portion ...
Cached Medicine Technology:Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinson's Disease 2Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinson's Disease 3CVS Caremark Corporation to Hold First Quarter 2012 Conference Call 2
(Date:7/29/2014)... (PRWEB) July 29, 2014 A ... the peer-reviewed journal Lipids in Health and Disease ... Nordic Naturals triglyceride-form best-selling Ultimate Omega®/ProOmega®. Consistently ranked ... to SPINS scan data, the product was shown ... other omega-3 products in the marketplace. The goal ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 The ... named a 2014 ASAE Power of A ... public awareness campaign to encourage everyone age six months ... , ASAE recognized NFID for its power to enrich ... and action among consumers and professionals about the importance ...
(Date:7/29/2014)... 29, 2014 The Eleventh Annual Business ... concluded with the $10,000 prize being presented to Ambika ... ) , The 11th Annual Summit was held on ... who can bring innovative products and services for the ... to have had such excellent array of young companies ...
(Date:7/29/2014)... July 29, 2014 Oxnard dentists , ... Dental Art Institute in Oxnard and Woodland Hills, Calif., regularly ... out or been removed due to dental disease. , However, ... two prosthodontists (experts in restoring and replacing teeth) want the ... implant specialists to perform their dental work and of not ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 "Acceptance, Recognition, ... man who faced his own demons and wants other men ... intended life partner left. A month later, he had no ... longer pay. When Raymond approached the government for assistance, the ... a two-year counselling program. But this approach didn’t get to ...
Breaking Medicine News(10 mins):Health News:Study Shows Nordic Naturals® Triglyceride-Form Ultimate Omega®/ProOmega® More Effective Than Krill Oil, Salmon Oil, and Ethyl Ester Fish Oil 2Health News:Study Shows Nordic Naturals® Triglyceride-Form Ultimate Omega®/ProOmega® More Effective Than Krill Oil, Salmon Oil, and Ethyl Ester Fish Oil 3Health News:National Foundation for Infectious Diseases Receives Top ASAE Honors for Keeping the Nation Flu-Focused 2Health News:Silicon Valley Boomer Venture Summit Names Bikanta Competition Winner 2Health News:Oxnard Dental Implant Experts Warn of Infections Around Dental Implants 2Health News:Oxnard Dental Implant Experts Warn of Infections Around Dental Implants 3Health News:Oxnard Dental Implant Experts Warn of Infections Around Dental Implants 4Health News:SBPRA Announces the Release of Its Newest Title, "Acceptance, Recognition, and Control (A.R.C.) Against Depression" 2
... Randy Dotinga HealthDay Reporter , MONDAY, April 11 ... talking on the phone and enjoying a cappuccino, know that ... things at once forever. In fact, new research finds ... multitask, possibly because they can,t refocus as well after getting ...
... Reinberg HealthDay Reporter , MONDAY, April 11 (HealthDay ... emissions of heart-harmful microscopic particles by 98 percent, which could ... suggests. The very tiny particles found in diesel engine ... caused by air pollution, but "if we use these particle ...
... California Institute for Quantitative Biosciences (QB3) has entered into ... its efforts to convert bioscience innovation into a driver ... Deloitte, which provides consulting, audit, tax and financial advisory ... help QB3 develop an "innovation ecosystem," bringing together the ...
... attending sexual health clinics in Gothenburg found that just four ... they had the disorder. However, a third of those who ... symptoms at a follow-up visit, reveals a thesis from the ... a specialist in skin and sexually transmitted infections at the ...
... from Tufts Medical Center researchers published today finds that a ... few other options because their disease has developed resistance to ... the study is the first published report showing that ... mouse model of the disease and is effective against human ...
... Jenifer Goodwin HealthDay Reporter , MONDAY, April 11 ... is showing promise in keeping a deadly type of cancerous ... the most common type of cancerous brain tumor. It,s also ... after diagnosis, said Dr. Isaac Yang, a neurosurgeon at University ...
Cached Medicine News:Health News:Multitasking Just a Bit Tougher for Older People: Study 2Health News:Multitasking Just a Bit Tougher for Older People: Study 3Health News:Emissions Trap Cuts Harmful Diesel Pollution 2Health News:Emissions Trap Cuts Harmful Diesel Pollution 3Health News:QB3, Deloitte collaborate to drive California bioscience innovation 2Health News:Recurring genital problems could be herpes 2Health News:New drug shows potential for treatment-resistant leukemia 2Health News:Brain Tumor Vaccine Shows Promise in Early Trials 2Health News:Brain Tumor Vaccine Shows Promise in Early Trials 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: